New England Journal of Medicine

Papers
(The H4-Index of New England Journal of Medicine is 295. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Clinical Characteristics of Coronavirus Disease 2019 in China19684
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine11057
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine7547
Dexamethasone in Hospitalized Patients with Covid-196617
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-16495
Remdesivir for the Treatment of Covid-19 — Final Report5231
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-194141
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma3660
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-193541
Mental Health and the Covid-19 Pandemic2928
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure2705
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2547
Dapagliflozin in Patients with Chronic Kidney Disease2469
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant2230
Fair Allocation of Scarce Medical Resources in the Time of Covid-192091
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting2086
Empagliflozin in Heart Failure with a Preserved Ejection Fraction2082
Virtually Perfect? Telemedicine for Covid-192071
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates2017
Neurologic Features in Severe SARS-CoV-2 Infection1935
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-191892
Cytokine Storm1877
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents1858
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series1857
Compassionate Use of Remdesivir for Patients with Severe Covid-191827
SARS-CoV-2 Infection in Children1754
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility1711
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination1676
Clinical Characteristics of Covid-19 in New York City1673
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results1669
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-191644
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant1610
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young1586
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-191563
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer1482
Multiorgan and Renal Tropism of SARS-CoV-21431
Initial Invasive or Conservative Strategy for Stable Coronary Disease1428
Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic1412
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-191398
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia1373
Once-Weekly Semaglutide in Adults with Overweight or Obesity1363
Genomewide Association Study of Severe Covid-19 with Respiratory Failure1361
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months1360
Hospitalization and Mortality among Black Patients and White Patients with Covid-191342
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-191323
Olaparib for Metastatic Castration-Resistant Prostate Cancer1267
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-191264
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-191237
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race1234
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-191206
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients1201
Monkeypox Virus Infection in Humans across 16 Countries — April–June 20221187
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults1136
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma1118
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes1116
Lecanemab in Early Alzheimer’s Disease1111
Developing Covid-19 Vaccines at Pandemic Speed1111
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers1104
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination1091
Severe Covid-191074
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure1053
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma1047
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-191044
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation1035
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host1032
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months1023
Efficacy of Tocilizumab in Patients Hospitalized with Covid-191021
Remdesivir for 5 or 10 Days in Patients with Severe Covid-191021
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer1018
Multisystem Inflammatory Syndrome in Children in New York State1017
Mild or Moderate Covid-191004
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington1003
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant996
Osimertinib in ResectedEGFR-Mutated Non–Small-Cell Lung Cancer977
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors975
Colchicine in Patients with Chronic Coronary Disease972
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19966
Spread of SARS-CoV-2 in the Icelandic Population962
Guillain–Barré Syndrome Associated with SARS-CoV-2958
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia949
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma939
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma932
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine931
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms925
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC922
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia906
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine904
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes898
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates889
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19877
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel869
The Effect of Advances in Lung-Cancer Treatment on Population Mortality861
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer857
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19852
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19849
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer848
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19847
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction845
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19835
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis820
Sotorasib for Lung Cancers with KRAS p.G12C Mutation818
How Structural Racism Works — Racist Policies as a Root Cause of U.S. Racial Health Inequities813
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants809
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer808
Tirzepatide Once Weekly for the Treatment of Obesity806
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis804
Waning Immunity after the BNT162b2 Vaccine in Israel796
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab787
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma777
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients776
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy774
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2773
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19768
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery765
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma758
Humoral Immune Response to SARS-CoV-2 in Iceland756
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol751
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer749
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination748
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction747
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers741
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine728
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19728
Responding to Covid-19 — A Once-in-a-Century Pandemic?722
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting709
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients706
HPV Vaccination and the Risk of Invasive Cervical Cancer697
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents690
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia689
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults681
Covid-19 and Health Care’s Digital Revolution674
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes668
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer665
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19664
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia660
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile654
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications654
Neuropathological Features of Covid-19646
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons643
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease639
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis637
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar633
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer629
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine626
Trial of Psilocybin versus Escitalopram for Depression623
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19619
Donanemab in Early Alzheimer’s Disease618
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination615
Covid-19 and Kidney Transplantation612
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment606
Autophagy in Human Diseases606
Vaccine Breakthrough Infections with SARS-CoV-2 Variants604
Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line602
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes585
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma580
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer579
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19578
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer577
ST-Segment Elevation in Patients with Covid-19 — A Case Series571
Empagliflozin in Patients with Chronic Kidney Disease570
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease569
New-Onset Diabetes in Covid-19566
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer559
Rivaroxaban in Peripheral Artery Disease after Revascularization553
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications548
Racial Health Disparities and Covid-19 — Caution and Context545
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa532
The Untold Toll — The Pandemic’s Effects on Patients without Covid-19530
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke527
Pathophysiology of Inflammatory Bowel Diseases522
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction516
Racial Bias in Pulse Oximetry Measurement515
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19514
Capmatinib inMETExon 14–Mutated orMET-Amplified Non–Small-Cell Lung Cancer513
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant510
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest504
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women503
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing501
Neutralizing Activity of BNT162b2-Elicited Serum500
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis497
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy496
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines489
Children with Covid-19 in Pediatric Emergency Departments in Italy489
The Toughest Triage — Allocating Ventilators in a Pandemic487
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine483
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer481
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China479
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes475
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations472
Acquired Resistance to KRASG12C Inhibition in Cancer470
Covid-19 — Implications for the Health Care System469
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer468
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma464
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia454
Avacopan for the Treatment of ANCA-Associated Vasculitis454
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19446
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine446
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection446
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients446
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization446
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19442
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer440
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer439
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma437
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers436
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel428
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer422
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease419
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma416
Transmission of SARS-CoV-2 in Domestic Cats415
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5415
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis411
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19410
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma409
Evinacumab for Homozygous Familial Hypercholesterolemia409
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China408
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease406
Evidence of Artemisinin-Resistant Malaria in Africa404
Homologous and Heterologous Covid-19 Booster Vaccinations404
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine403
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age403
A Population-Based Study of Genes Previously Implicated in Breast Cancer400
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation399
Microvascular Injury in the Brains of Patients with Covid-19392
Structural Racism, Social Risk Factors, and Covid-19 — A Dangerous Convergence for Black Americans392
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase391
A Bivalent Omicron-Containing Booster Vaccine against Covid-19390
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma386
Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer386
Barrier Enclosure during Endotracheal Intubation384
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19384
Diffuse Large B-Cell Lymphoma382
SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia378
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer375
Spectrum of Fibrotic Lung Diseases375
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines374
Migraine372
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma372
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections367
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons367
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure366
Race and Genetic Ancestry in Medicine — A Time for Reckoning with Racism363
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer360
Collateral Effect of Covid-19 on Stroke Evaluation in the United States357
Ofatumumab versus Teriflunomide in Multiple Sclerosis355
Endometrial Cancer352
Osteoarthritis of the Knee352
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women351
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS350
Acute-on-Chronic Liver Failure350
0.02731990814209